Reviewing the Compounding Risks for Tuberculosis DrugInduced Liver Injury in a Patient with Transfusion Dependent Thalassaemia
https://doi.org/10.47836/mjmhs.19.4.51
- Author:
Nursafinas Rofii
1
;
Ummi Nadira Daut
2
;
Su Yin Lau
1
Author Information
1. Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia&Gastroenterology and Hepatology Unit, Hospital Pengajar University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2. Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia&Respiratory Unit, Hospital Pengajar University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
- Publication Type:Case Reports
- Keywords:
Antitubercular agents, Case report, Drug-induced liver injury, Tuberculosis, Thalassaemia major
- From:Malaysian Journal of Medicine and Health Sciences
2023;19(No.4):365-367
- CountryMalaysia
- Language:English
-
Abstract:
A patient presents with jaundice three weeks into commencement of anti-tuberculosis therapy (ATT). Tuberculosis
drug-induced liver injury (TB-DILI) is a main concern in patients commencing ATT. Studies have reported various
risk factors associated with TB-DILI, urging vigilance in monitoring liver enzymes in these patients. We aim to review
the causes of jaundice in a patient with transfusion dependent thalassaemia commenced on ATT and highlight the
risk factors associated with TB-DILI.
- Full text:11.2023my1602.pdf
